Return to Academic Venture Fund
2017: The Future of Pharma is Sustainable
Many vital medicines are unsustainable to mass-produce, demanding complex, energy-intensive manufacturing processes and leaving toxic wastes. This team is finding new ways to make drug manufacturing more efficient and sustainable. Partnering with Boston-area Snapdragon Chemistry, the researchers are testing a new chemical synthesis process–recently discovered in Song Lin’s lab–that converts cheap, abundant natural resources like carbon dioxide into pharmaceuticals in a single operation. Combining this discovery with continuous-flow processes suitable for commercialization promises cleaner, greener pharmaceuticals.
Investigators: Song Lin, Héctor Abruña, Abraham Stroock